tiprankstipranks
Trending News
More News >
Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
US Market

Milestone Pharmaceuticals (MIST) Income Statement

Compare
593 Followers

Milestone Pharmaceuticals Income Statement

Last quarter (Q1 2025), Milestone Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Milestone Pharmaceuticals's net income was $0.00. See Milestone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 1.00M$ 5.00M$ 15.00M$ 0.00
Gross Profit
$ 0.00$ 1.00M$ 4.52M$ 15.00M$ -376.00K
Operating Expenses
$ 31.10M$ 62.10M$ 64.64M$ 58.07M$ 50.71M
Depreciation and Amortization
$ -3.90M$ 92.00K$ 480.00K$ 362.00K$ 376.00K
EBITDA
$ -42.10M$ -56.84M$ -58.36M$ -42.98M$ -50.71M
Operating Income
$ -42.10M$ -61.10M$ -59.64M$ -43.07M$ -50.71M
Other Income/Expenses
$ 324.00K$ 1.41M$ 1.25M$ 220.00K$ 726.00K
Pretax Income
$ -41.78M$ -59.69M$ -58.39M$ -42.85M$ -49.98M
Net Income
$ -41.52M$ -59.69M$ -57.13M$ -42.63M$ -49.97M
Per Share Metrics
Basic EPS
$ -0.67$ -1.39$ -1.35$ -1.02$ -1.70
Diluted EPS
$ -0.67$ -1.39$ -1.35$ -1.02$ -1.70
Weighted Average Shares Outstanding
62.21M 42.96M 42.45M 41.83M 29.34M
Weighted Average Shares Outstanding (Diluted)
62.21M 42.96M 42.45M 41.83M 29.34M
Currency in USD

Milestone Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis